|
Delayed
Toronto S.E.
19:22:56 20/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 9.400 CAD | +2.40% |
|
-5.05% | +18.69% |
| 10-05 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 10-05 | Satellos Bioscience Receives US Patent for Forazapadin | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.40% | -5.05% | -26.96% | -19.80% | +18.69% | -0.84% | +95.83% | -47.78% | - | 138M | |
| +0.79% | -6.46% | -7.71% | +25.25% | +62.91% | +52.86% | +71.34% | +1.83% | - | 65.83B | |
| +1.92% | +10.35% | +13.88% | +10.62% | +16.21% | +13.02% | +87.74% | -14.94% | +237.66% | 51.87B | |
| +6.91% | +8.57% | -10.12% | +3.53% | +8.84% | +6.88% | +72.12% | +206.56% | +5,247.50% | 51.2B | |
| +1.06% | +3.01% | -0.51% | +31.69% | +19.12% | +26.63% | +45.65% | +6.76% | +260.81% | 43.76B | |
| +2.69% | +8.95% | +4.01% | +22.46% | +25.18% | +19.38% | +130.20% | +2.07% | +1,053.18% | 42.09B | |
| +6.23% | +3.03% | +0.72% | +7.63% | +143.75% | +259.47% | +594.14% | +620.94% | - | 39.04B | |
| -0.40% | +9.42% | +10.03% | +12.29% | +14.51% | +18.44% | +59.06% | +10.14% | +162.29% | 34B | |
| +3.84% | -4.94% | -0.60% | +35.34% | +59.19% | +42.35% | +8.92% | -57.55% | - | 25.2B | |
| +2.36% | +5.34% | +15.13% | +40.88% | +28.37% | +30.98% | +26.07% | -11.13% | +125.09% | 22.8B | |
| +0.86% | +0.89% | -8.37% | -2.56% | -5.67% | -16.81% | -1.22% | -66.67% | - | 22.41B | |
| -0.25% | -1.62% | -21.31% | -11.03% | -45.29% | -43.29% | +279.67% | +256.50% | +576.76% | 20.81B | |
| +1.58% | +3.10% | +0.74% | +19.10% | +11.95% | +15.50% | +174.28% | +234.37% | +1,934.26% | 17.3B | |
| -1.70% | -2.53% | -2.12% | -3.35% | +172.60% | +148.30% | +359.39% | +1,412.56% | +703.28% | 14.99B | |
| +1.36% | +6.50% | +10.77% | +14.14% | +44.60% | +83.50% | +200.24% | +192.88% | +439.86% | 15.53B | |
| +0.08% | +0.69% | +1.20% | +11.11% | +26.60% | +23.63% | +71.78% | -29.45% | +86.81% | 15.37B | |
| +1.38% | +4.25% | -2.06% | -7.57% | - | - | - | - | - | 15.1B | |
| +5.06% | +4.91% | +12.44% | +42.79% | +57.27% | +70.37% | +69.20% | -25.56% | +277.97% | 14.32B | |
| +3.54% | +4.05% | +1.39% | -3.78% | +19.33% | +2.09% | +498.47% | - | - | 13.77B | |
| +5.23% | +7.15% | +3.86% | +5.96% | -3.36% | -6.56% | -22.33% | -36.28% | +107.82% | 12.97B | |
| Average | +2.23% | -0.59% | -0.28% | +11.74% | +35.52% | +39.26% | +148.45% | +147.51% | +862.56% | 26.93B | |
| Weighted average by Cap. | +2.40% | +0.23% | +0.54% | +15.17% | +37.16% | +43.64% | +138.37% | +125.49% | +1,161.44% |
- Stock Market
- Stocks
- MSCL Stock
- Sector Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
